A5022041494- Ovarian cancer diagnosis and treatment
- COVID-19 and healthcare impacts
- Intraperitoneal and Appendiceal Malignancies
- Endometrial and Cervical Cancer Treatments
- International Law and Aviation
- Uterine Myomas and Treatments
- Pelvic floor disorders treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Enhanced Recovery After Surgery
- Congenital Heart Disease Studies
- Trauma and Emergency Care Studies
- Cancer Diagnosis and Treatment
- Cardiovascular Issues in Pregnancy
- Reproductive Biology and Fertility
- Ovarian function and disorders
- Renal cell carcinoma treatment
- Endometriosis Research and Treatment
- Respiratory Support and Mechanisms
- Tissue Engineering and Regenerative Medicine
- Advances in Oncology and Radiotherapy
- Radiation Dose and Imaging
- Cervical Cancer and HPV Research
- Global Cancer Incidence and Screening
Istanbul University-Cerrahpaşa
2015-2024
Laboratoire des Sciences de l'Ingénieur, de l'Informatique et de l'Imagerie
2022
Urology Foundation
2021
NIHR Birmingham Biomedical Research Centre
2021
University of Birmingham
2021
Yorkshire Cancer Research
2021
Association for Cancer Surgery
2021
Institut de Virologie
2021
Istanbul University
2015-2020
<h3>Introduction/Background</h3> This study's objectives include identifying various molecular subgroups in endometrioid-type endometrial cancers (EEC), investigating the association between profile and clinicohistopathological data determining low intermediate risk EC groups by merging collected. <h3>Methodology</h3> Retroprospective analysis was performed on 1040 individuals who underwent surgery were monitored January 2000 June 2022. Out of 900 EEC cases, 72 had recurrence. Matching done...
<title>Abstract</title> <bold>Purpose</bold>: We investigated the outcome of neoadjuvant chemotherapy (NACT) followed by interval cytoreductive surgery and primary (PCS) in patients with platinum-sensitive or resistant advanced epithelial ovarian cancer. <bold>Materials methods:</bold> The inclusion criteria fit 298 who underwent (PCS group n=158) (NACT n=140). Differences characteristic features, responses, prognosis were compared. <bold>Results:</bold> Although median DFS was similar...
<b><i>Introduction:</i></b> The aim of this study was to compare the disease-free survival (DFS) and overall (OS) patients who underwent interval cytoreductive surgery after 3–4 cycles or 6 neoadjuvant chemotherapy (NACT) in advanced epithelial ovarian cancer patients. <b><i>Methods:</i></b> Out 219 with cancer, 123 received 96 platinum-based NACT. Afterward, laparotomy performed for surgery. <b><i>Results:</i></b> No...
Amaç: Kalp hastalığıyla komplike olan gebeliklerde maternal ve fetal sonuçların değerlendirilmesidir. Gereç Yöntemler: 1997-2012 yılları arasında gebe polikliniğinde antenatal takipleri yapılmış doğumunu yine bu merkezde gerçekleştirmiş, kalp hastalığı 222 gebenin dosyası retrospektif olarak incelendi. hastalığının türüne New York Derneği [New Heart Association (NYHA)]'nin kardiyak durum fonksiyonel sınıflamasına göre perinatal sonuçlar değerlendirildi. Bulgular: Romatolojik konjenital...
<h3>Introduction/Background</h3> The aim of this study was to compare the disease-free survival (DFS) and overall (OS) patients who underwent interval cytoreductive surgery after 3–4 cycles or 6 neoadjuvant chemotherapy (NACT) in advanced epithelial ovarian cancer whom primary could not be performed. <h3>Methodology</h3> Out 219 with cancer,123 received 96 platinum based NACT. Afterwards, laparotomy performed for surgery. <h3>Results</h3> were evaluated, no statistically significant...
<h3>Introduction/Background</h3> Uterine sarcomas (US) are aggressive tumors with a 45–73% recurrence rate. Cytoreductive surgery is the mainstay treatment in uterine sarcoma management. Systemic chemotherapy also an option for pati-ents recurrent, metastatic, irresectable leiomyosarcoma. This study aims to compare efficacy of secondary cytoreductive and patients recurrent <h3>Methodology</h3> Recorded data from 45 were analyzed retrospectively. Twenty-three US cases treated 22 included...
<h3>Introduction/Background</h3> The factors affecting the rate of optimal CR for patients with advanced ovarian cancer were investigated in primary and interval cytoreductive surgery. aim this study to develop a scoring system that is foreseen who will be able <h3>Methodology</h3> We conducted retrospective analysis diagnosed underwent cytoreduction at our clinic between 2010 2020 <h3>Results</h3> Total 340 180 160 them had undergone CR, respectively was included study. In group, ascites...
<h3>Introduction/Background</h3> Carcinoma vulva is a rare disease accounting for 1.3% of all gynecological malignancies. The aim the present study to analyze clinicopathological characteristics women with squamous and glandular cell carcinoma who underwent primary surgical management. <h3>Methodology</h3> A retrospective analysis was conducted on 649 patients were treated at multicenter in Turkey. <h3>Results</h3> mean age 63.2 ± 12.8 years. most common location lateral (55.5%) then midline...